Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

05-883 Anti-tPA (Tissue Plasminogen Activator) Antibody, clone GMA-043

Detect tPA (Tissue Plasminogen Activator) using this Anti-tPA (Tissue Plasminogen Activator) Antibody, clone GMA-043 validated for use in ELISA & WB.

Anti-tPA (Tissue Plasminogen Activator) Antibody, clone GMA-043: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.
Research Category: Metabolism Research Sub-Category: Enzymes & Biochemistry Gene Symbol: PLAT, Reteplase, reteplase, T-PA, alteplase, DKFZp686I03148, Alteplase, tPA, TPA UniProt Number: P00750
05-883
100 µg  
Purchase on Sigma-Aldrich

Offerte speciali

Panoramica

Replacement Information

Offerte speciali

100% Performance Guaranteed

Tabella delle specifiche principali

Species ReactivityKey ApplicationsHostFormatAntibody Type
HELISA, WBMPurifiedMonoclonal Antibody
Description
Catalogue Number05-883
Brand Family Upstate
Trade Name
  • Upstate
DescriptionAnti-tPA (Tissue Plasminogen Activator) Antibody, clone GMA-043
References
Product Information
FormatPurified
Presentation100 µg of protein G purified mouse IgG1 lyophilized from 10 mM NaH2PO4, 0.15 M NaCl, 1.0% mannitol, pH 7.4.
Quality LevelMQ100
Applications
ApplicationDetect tPA (Tissue Plasminogen Activator) using this Anti-tPA (Tissue Plasminogen Activator) Antibody, clone GMA-043 validated for use in ELISA & WB.
Key Applications
  • ELISA
  • Western Blotting
Biological Information
ImmunogenPurified human tissue plasminogen activator (tPA)
Cloneclone GMA-043
HostMouse
SpecificitytPA
IsotypeIgG1
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene encodes tissue-type plasminogen activator, a secreted serine protease which converts the proenzyme plasminogen to plasmin, a fibrinolytic enzyme. Tissue-type plasminogen activator is synthesized as a single chain which is cleaved by plasmin to a two chain disulfide linked protein. This enzyme plays a role in cell migration and tissue remodeling. Increased enzymatic activity causes hyperfibrinolysis, which manifests as excessive bleeding; decreased activity leads to hypofibrinolysis which can result in thrombosis or embolism. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms.
Gene Symbol
  • PLAT
  • Reteplase
  • reteplase
  • T-PA
  • alteplase
  • DKFZp686I03148
  • Alteplase
  • tPA
  • TPA
Purification MethodProtein G Purified
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P00750 # Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events. Play a direct role in facilitating neuronal migration.
SIZE: 562 amino acids; 62917 Da
SUBUNIT: Heterodimer of chain A and chain B held by a disulfide bond. Binds to fibrin with high affinity. This interaction leads to an increase in the catalytic efficiency of the enzyme between 100-fold and 1000-fold, due to an increase in affinity for plasminogen. Similarly, binding to heparin increases the activation of plasminogen. Binds to annexin A2, cytokeratin-8, fibronectin and laminin. Binds to mannose receptor and the low- density lipoprotein receptor-related protein (LRP1); these proteins are involved in TPA clearance. Yet unidentified interactions on endothelial cells and vascular smooth muscle cells (VSMC) lead to a 100-fold stimulation of plasminogen activation. In addition, binding to VSMC reduces TPA inhibition by PAI-1 by 30-fold. Binds LRP1B; binding is followed by internalization and degradation.
SUBCELLULAR LOCATION: Secreted, extracellular space.
TISSUE SPECIFICITY: Synthesized in numerous tissues (including tumors) and secreted into most extracellular body fluids, such as plasma, uterine fluid, saliva, gingival crevicular fluid, tears, seminal fluid, and milk.
DOMAIN: SwissProt: P00750 Both FN1 and one of the kringle domains are required for binding to fibrin. & Both FN1 and EGF-like domains are important for binding to LRP1. & The FN1 domain mediates binding to annexin A2. & The second kringle domain is implicated in binding to cytokeratin-8 and to the endothelial cell surface binding site.
PTM: The single chain, almost fully active enzyme, can be further processed into a two-chain fully active form by a cleavage after Arg-310 catalyzed by plasmin, tissue kallikrein or factor Xa. & Differential cell-specific N-linked glycosylation gives rise to two glycoforms, type I (glycosylated at Asn-219) and type II (not glycosylated at Asn-219). The single chain type I glycoform is less readily converted into the two-chain form by plasmin, and the two-chain type I glycoform has a lower activity than the two- chain type II glycoform in the presence of fibrin. & N-glycosylation of Asn-152; the bound oligomannosidic glycan is involved in the interaction with the mannose receptor. & Characterization of O-linked glycan was studied in Bowes melanoma cell line.DISEASE:SwissProt: P00750 # Increased activity of TPA causes hyperfibrinolysis, with excessive bleeding as a consequence. & Defective release of TPA causes hypofibrinolysis, leading to thrombosis or embolism.
SIMILARITY: Belongs to the peptidase S1 family. & Contains 1 EGF-like domain. & Contains 1 fibronectin type-I domain. & Contains 2 kringle domains. & Contains 1 peptidase S1 domain.
Molecular WeightMr 63kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality Assuranceroutinely evaluated by immunoblot on human tPA
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage Conditionsstable 2 years at -20°C from date of shipment
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
05-883 04053252670435

Documentation

Anti-tPA (Tissue Plasminogen Activator) Antibody, clone GMA-043 MSDS

Titolo

Scheda di sicurezza (MSDS) 

Anti-tPA (Tissue Plasminogen Activator) Antibody, clone GMA-043 Certificati d'Analisi

TitoloNumero di lotto
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) - 2387482 2387482
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) - 2446690 2446690
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) 2981172
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) 3134099
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) 3117837
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) - 1956576 1956576
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) - 2030004 2030004
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) - 2219270 2219270
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) - 2283788 2283788
Anti-tPA (Tissue Plasminogen Activator), clone GMA-043 (mouse monoclonal IgG1) - 2302726 2302726
Show more

Riferimenti bibliografici

Panoramica dei riferimenti bibliograficiCodice d'identificazione nel Pub Med
Tissue plasminogen activator as a modulator of neuronal survival and function
Tsirka, Stella E
Biochem Soc Trans, 30:222-5 (2002)  2002

12023855 12023855
Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice
Gladstone, D J and Black, S E
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 165:311-7 (2001)  2001

11517650 11517650
Tissue-type plasminogen activator: characteristics, applications and production technology.
Rouf, S A, et al.
Biotechnol. Adv., 14: 239-66 (1996)  1996

Mostra il sommario 		14537155 14537155